Scribd Logo
Upload

Welcome to Scribd!

  • 10 views

    E-ROK in Terminal Cancer (Estimated Remaining OK Days)

    Uploaded by

    Scivision Publishers
    Terminal cancer, Surgery, Chemotherapy.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    E-ROK in Terminal Cancer (Estimated Remaining OK Days)

    Uploaded by

    Scivision Publishers
    10 views1 page
    Terminal cancer, Surgery, Chemotherapy.

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Terminal cancer, Surgery, Chemotherapy.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    10 views1 page

    E-ROK in Terminal Cancer (Estimated Remaining OK Days)

    Uploaded by

    Scivision Publishers
    Terminal cancer, Surgery, Chemotherapy.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Letter to Editor ISSN 2689-1093

    Surgical Research

    E-ROK in Terminal Cancer (Estimated Remaining OK Days)


    Einer-Jensen N*

    *
    Correspondence:
    Einer-Jensen N, University of Southern Denmark, Denmark,
    University of Southern Denmark, Denmark. E-mail: nielseinerjensen@gmail.com.

    Received: 20 Apr 2024; Accepted: 23 Apr 2024; Published: 25 Apr 2024

    Citation: Einer-Jensen N. E-ROK in Terminal Cancer (Estimated Remaining OK Days). Surg Res. 2024; 6(2): 1-1.

    Keywords
    Terminal cancer, Surgery, Chemotherapy.

    In general: Patients do not want to die, and doctors do not want their patients to die. Both parts involved want to extend life, even
    in terminal cases. Drastic surgery or chemotherapy may be started to increase the number of days surviving, and life may indeed be
    extended somewhat. However, the remaining life may end up being a struggle with a poor quality of life trying to overcome the stress
    of the treatment.

    The author suggest introduction of a new term: Estimated Remaining OK Days (E-ROK).
    Reason: The number of remaining OK days is more important than the number of surviving days. Patients, their relatives, and the
    doctors may (and often do) discuss the pro et contra before an eventual start of extensive treatment in terminal cases. The base of the
    discussion could be E-ROK. How many OK days are left after a drastic treatment - how many OK days remains with a more traditional
    approach. The author is aware that the discussion may be based on a comparison between two rather uncertain numbers - but it is still
    important.

    E-ROK could be introduced as a parameter in cancer research proposals.

    © 2024 Einer-Jensen N. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License

    Surg Res, 2024 Volume 6 | Issue 2 | 1 of 1

    You might also like